Pan-African ยท Africa
Guinea-Bissau denies approval of controversial newborn vaccine trial
By: Fekria Mohsen
Guinea-Bissau has denied approving a controversial newborn vaccine trial, following. The nation's authorities say no such approval has been granted, underscoring ongoing questions about the trial's status.
Guinea-Bissau has denied reports that it approved a controversial vaccine trial involving newborns. In a statement responding to coverage by the publication, authorities clarified that no official authorization for a trial of vaccines in newborns has been granted. The publication's article raised concerns about ethical approvals and regulatory oversight, prompting scrutiny from public health observers. Officials emphasized that any research involving vulnerable populations, especially newborns, must undergo rigorous review and obtain appropriate permissions before proceeding. The clarification comes as debates over vaccine research ethics and regulatory processes intensify in parts of Africa, where clinical trials can affect public trust in health interventions. At this time, there is no confirmed information indicating that Guinea-Bissau has moved forward with the trial, and researchers or sponsors have not publicly detailed plans or timelines. The situation highlights the broader need for transparent regulatory practices and clear communication with communities when handling trials involving newborns.